FLUPHENAZINE DECANAOTE vs FLUPHENAZINE ENANTHATE
Adverse effects/events ‐ extrapyramidal symptoms ‐ medium term Number of instances of extrapyramidal symptoms · patients with schizophrenia
It is very uncertain whether FLUPHENAZINE DECANAOTE changes extrapyramidal adverse effects ‐ general compared with FLUPHENAZINE ENANTHATE (very low certainty).
1 finding from 1 review
- Fluphenazine decanoate (depot) and enanthate for schizophrenia 2015 · Cochrane Headline outcomes onlyRR 1.14 [0.79, 1.64]2 studies · 49 participantsVery low